Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Johan Neyts and Sebastiaan Ter Horst.
Johan Neyts
Connection Strength
0.232
Sebastiaan Ter Horst
  1. Corrigendum to "itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens". EBioMedicine. 2021 Jul; 69:103454.
    View in: PubMed
    Score: 0.060
  2. Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial. EBioMedicine. 2021 Apr; 66:103288.
    View in: PubMed
    Score: 0.058
  3. A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate. Nature. 2021 02; 590(7845):320-325.
    View in: PubMed
    Score: 0.057
  4. Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity. Proc Natl Acad Sci U S A. 2020 10 27; 117(43):26955-26965.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.